Bromelain
규격
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R)-5-acetamido-6-hydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-5-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethIUPAC 명칭
C39H66N2O29화학식
1026.9 g/mol분자량
alpha-L-fucopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->6)-[beta-D-xylopyranosyl-(1->2)]-beta-D-mannopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)]-2-acetamido-2-deoxy-D-glucopyranose; Fuc-alpha-(1->3)-[Man-alpha-(1->6)-[Xyl-beta-(1->2)]-Man-beta-(1->4)-GlcNAc-beta-(1->4)]-GlcNAc; alpha-L-fucopyranosyl-(1->3)-(alpha-D-mannopyranosyl-(1->6)-(beta-D-xylopyranosyl-(1->2))-beta-D-mannopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4))-2-acetamido-2-deoxy-D-glucopyranose; Fuc-alpha-(1->3)-(Man-alpha-(1->6)-(Xyl-beta-(1->2))-Man-beta-(1->4)-GlcNAc-beta-(1->4))-GlcNAc; RefChem:806780; GlyTouCan:G64799PD; G64799PD; MUXF; carbohydrate moiety of bromelain; CHEBI:53469; M0XF(3); Bromelain, Technical Grade; bromelaine; alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc; Epitope ID:115005; SCHEMBL29408716; UNMLVGNWZDHBRA-UFAVQCRNSA-N; GLXC-19140; Q27124066; N_FULL_22100100000000_GS_1023_c1; Man(a1-6)[Xyl(b1-2)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc; alpha-L-Fuc-(1->3)-[alpha-D-Man-(1->6)-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)]-D-GlcNAc; alpha-L-fucosyl-(1->3)-[alpha-D-mannosyl-(1->6)-[beta-D-xylosyl-(1->2)]-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)]-N-acetyl-D-glucosamine동의어
Bromelain 판매 기업
CT
Công ty TNHH Phil Inter PharmaViet Nam(주
(주)동구바이오제약Republic of Korea동국
동국제약(주)Republic of Korea(주
(주)테라젠이텍스Republic of Korea(주
(주)에이프로젠바이오로직스Republic of Korea(주
(주)대웅제약Republic of Korea일양
일양약품(주)Republic of Korea아주
아주약품(주)Republic of Korea(주
(주)넥스팜코리아Republic of Korea동화
동화약품(주)Republic of Korea영진
영진약품(주)Republic of Korea1/6 페이지